Mohamad Hanouneh
Overview
Explore the profile of Mohamad Hanouneh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hannouneh Z, Cervantes C, Hanouneh M, Atta M
Glomerular Dis
. 2025 Mar;
5(1):119-132.
PMID: 40084183
Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2is) have significantly impacted the management of diabetic kidney disease (DKD) and heart failure (HF), providing benefits beyond glycemic control. This review examines the mechanisms...
2.
Hanouneh M, Stewart S, Aktay R, Fang A, Cervantes C
Kidney Int
. 2024 Nov;
106(6):1190.
PMID: 39577995
No abstract available.
3.
Hannouneh Z, Cervantes C, Sperati C, Hanouneh M
BMC Nephrol
. 2024 Sep;
25(1):315.
PMID: 39333966
Background: Familial hypokalemic periodic paralysis (HypoPP) is an uncommon genetic disorder characterized by recurrent episodes of muscle weakness and hypokalemia, typically starting in early adulthood. The existence of hyperthyroidism in...
4.
Hanouneh M, Le D, Jaar B, Tamargo C, Cervantes C
Diagnostics (Basel)
. 2024 Jul;
14(13).
PMID: 39001247
Background: There have been several recent advances in the care of patients with chronic kidney disease (CKD), including the use of sodium glucose cotransporter 2 (SGLT2) inhibitors and selective mineralocorticoid...
5.
Haq K, Hannouneh Z, Cervantes C, Hanouneh M
Cleve Clin J Med
. 2024 Jun;
91(6):345-351.
PMID: 38830705
No abstract available.
6.
Tamargo C, Hanouneh M, Cervantes C
J Clin Med
. 2024 May;
13(9).
PMID: 38730983
Acute kidney injury (AKI) is a complex and life-threatening condition with multifactorial etiologies, ranging from ischemic injury to nephrotoxic exposures. Management is founded on treating the underlying cause of AKI,...
7.
Hanouneh M, Monroy Trujillo J
Cleve Clin J Med
. 2024 Mar;
91(3):155-160.
PMID: 38429003
No abstract available.
8.
9.
Hanouneh M, Cervantes C
Am J Kidney Dis
. 2023 Sep;
82(4):A11-A14.
PMID: 37739625
No abstract available.
10.
Hannouneh Z, Bagnasco S, Hanouneh M
Kidney360
. 2023 Jun;
4(6):e863-e864.
PMID: 37384891
No abstract available.